2.Danggui Shaoyao Powder combined with trabeculectomy and bevacizumab on neovascular glaucoma
International Eye Science 2015;(1):89-91
Abstract?AlM: To study the effect of Danggui Shaoyao Powder combined with trabeculectomy and bevacizumab on neovascular glaucoma? METHODS: Neovascular glaucoma patients were enrolled from January 2011 to February 2014 in our hospital, according to the different methods of treatment were divided into observation group given traditional Chinese medicine and Western medicine combined with trabeculectomy, and control group received Western medicine combined with trabeculectomy. Visual acuity, intraocular pressure, retinal thickness were compared.?RESULTS: Visual acuity level : 1wk; 6, 12mo after treatment, visual acuity in observation group were significantly higher than that in control group (0. 41±0. 07 vs 0. 27±0. 04, 0. 52±0. 08 vs 0. 38±0. 06, 0. 72±0. 14 vs 0. 54± 0. 08 ); lntraocular pressure: 1wk; 6, 12mo after treatment, intraocular pressure in observation group were significantly lower than that in control group (15. 11±3. 22 vs 22.32±5.34, 18.64±5.08 vs 26.67±6.22, 17.18±3.76 vs 22. 42 ± 4. 32 ) mmHg; Retinal nerve fiber layer thickness:12mo after treatment, nerve fiber layer thickness in observation group was significantly higher than that in control group (90. 41±10. 52 vs 78. 64±8. 24, 88. 38±12. 12 vs 72. 37± 8. 82, 73. 21 ± 8. 46 vs 60. 25 ± 7. 23, 75. 35 ± 8. 13 vs 62. 63±7. 29)μm.?CONCLUSlON:Danggui Shaoyao Powder combined with trabeculectomy and bevacizumab on neovascular glaucoma can promote visual acuity recovery, control intraocular pressure, and improve the retinal nerve fiber layer thickness.
4.Syndrome of Inappropriate Antidiuretic Hormone Secretion in Small Cell Lung Cancer
Chinese Journal of Clinical Oncology 2009;36(21):1256-1259
Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) was a common complica-tion of small cell lung cancer (SCLC). Recent studies have suggested that the origin of this disease is related to seceration of tumor cells and application of medecine. The inappropriate antidiuretic hormone secretion can lead to disturbance of metabolism of water and sodium, resulting in hyponatremia. Because the symp-toms are atypical, the diagnosis is difficult. Many cases are misdiagnosed or misseddiagnosed. The primary tumor must be treated and the restriction of water intake is the main and effective method to deal with SIADH. Prognosis of SCLC patients with SIADH is poor in most reports.
5.Effects and safety of citalopram combined with low-dose risperidone on refractory depression
Chinese Journal of Postgraduates of Medicine 2008;31(19):12-14
Objective To explore the effects and safety of citalopram combined with low-dose risperidone on refractory depression. Methods All of 54 patients with the refractory depression were ran-domly divided into two groups: augmented treatment group (taken citalopram 20 mg/d, risperidone 0.5-2.0mg/d) and mono-thempy group (taken citalopram alone 20 mg/d). The treatment lasted for 6 weeks. They were estimated with Hamilton depression scale (HAMD), Hamilton anxiety scale (HAMA), and treatment emergent symptom scale (TESS) at baseline and every two weeks subsequently. Results In the augment-ed treatment group, total effective rate was 60.7% and recovery and excellence rate was 50.0%, while that was 26.9% and 15.4% in mono-therapy group (P< 0.05). The adverse effect of two groups was minor. Conclu-sion Rispefidone may be a useful and safe adjunct to citalopram in treatment of refractory depression.
6.Evidence-based Pharmacy in Clinical Pharmaceutical Practice
China Pharmacy 2001;12(2):75-77
AIM:To introduce evidence-based pharmacy in respect to the definition,contents and principle in applying to decisions of clinical pharmacotherapy.METHODS:We focused the discussion on a brief summary of different study designs,factors affecting the strength of scientific evidence,and interpretation of the data.RESULTS:These application principles are helpful to guide clinical pharmacists solving clinical problems.CONCLUSION:Clinical pharmacist should use concepts in the evidence-based practice when making pharmacotherapeutic decisions in the future.
7.Clinical Follow-up Results in 33 Patients With Pacemaker Implantation With Home Monitoring System
Chinese Circulation Journal 2015;(12):1178-1181
Objective: To study the clinical value of home monitoring system of pacemaker and implantable cardioverter-deifbrillators (ICD) in relevant patients.
Methods: A total of 33 patients with home monitoring system of pacemaker implantation or ICD treated in our hospital from 2011-02 to 2014-07 were retrospectively recruited. There were 28 patients with dual chamber pacemaker, 4 with ICD and 1 with cardiac resynchronization therapy pacemaker (CRTP). The patients included 23 male and 10 female at the age of (68.4 ± 9.2) years. The rate of successful data transmission, threshold changes and arrhythmia occurrence were analyzed.
Results: Up to 2014-10, a total 24516 messages were successfully transmitted with the success rate of 97.4%, the rate of no-message transmission was 2.6%. The home monitoring system fund 89 abnormal events including 73 disease related events (82.0%) and 16 system related events (18.0%).
Conclusion: Home monitoring system was a safe, reliable and effective monitoring equipment for cardiovascular implantable electronic devices; according to transmitted message, the parameters of devices could be adjusted in time for treating arrhythmia in relevant patients.
8.Improving of infant incubator disinfection and built-in disinfection device
China Medical Equipment 2013;(11):98-99
Objective: To imrove the current situation that disinfection is inconvenient and ineffective when infant incubators are used. Methods: To make some improvements without changing the structure and performance of existing infant incubators. Results: Built-in disinfection device is designed to overcome the difficult operation, poor effect and inconvenience in use. Conclusion:It has been awarded“the state utility model”for its safety and convenience (patent no:ZL200520117573.9).
9.Analysis on Operation Selection to Myomectomy of Child-bearing Period (Report of 200 Cases)
Journal of Zhejiang Chinese Medical University 2013;(7):886-888
[Objective] To compare the clinical cure effects of different operations on myomectomy, and screen out best clinical treatment for hysteromyoma in child-bearing period. [Method] Trace back and analyse 200 cases of such patients, divide them into laparotomy group, laparoscope group, vaginal group and UAE group under different therapies, compare cure effect analysis. [Result] On operation time, operation bleeding and evacuation time, the UAE group ,vaginal and laparoscope groups were successively better than the laparotomy group; but on post-operation medication rate and average in-hospital days, the UAE group was successively less than laparoscope, vaginal and laparotomy groups. On complication rate,the laparoscope was successively less than UAE, vaginal and laparotomy groups.[Conclusion] 4 therapies have respective advantages, UAE and laparoscope myomectomy have little trauma, quick re-covery and reliable cure effect, however, laparotomy can't be completely replaced owing to its wide indications.
10.Sodium hyaluronate injection immediately versus 2 weeks after arthroscopic debridement for knee osteoarthritis
Chinese Journal of Tissue Engineering Research 2013;(35):6375-6380
BACKGROUND:Sodium hyaluronate injection after arthroscopic debridement of knee osteoarthritis can reduce postoperative pain and improve joint function, but there is a controversy on the time for the hyaluronate injection after arthroscopic debridement of knee osteoarthritis.
OBJECTIVE:To observe the time of hyaluronate injection after arthroscopic debridement of knee osteoarthritis, and to compare recent rehabilitation effect of knee sodium hyaluronate injection for knee function after
arthroscopic debridement of knee osteoarthritis between injection just after knee arthroscopy and injection 2 weeks after knee arthroscopy.
METHODS:The clinical data of 100 knee osteoarthritis patients undergoing sodium hyaluronate injection
immediately and 2 weeks after arthroscopic debridement were analyzed with prospective randomized control ed trial method, and the preoperative visual analog scale score, Lysholm score, 6 weeks postoperative visual analog scale score, 3 months postoperative visual analog scale score, and 3 months postoperative Lysholm score were recorded. The effects of recently rehabilitation of knee joint after surgery in two groups were compared.
RESULTS AND CONCLUSION:There was no significant difference in postoperative visual analog scale score between immediate injection group (6.52±2.38) and 2 weeks postoperative injection group (6.54±2.37). The preoperative Lysholm score in the immediate injection group (43.44±16.18) was lower than that in the 2 weeks postoperative injection group (51.12±16.3). The 6 weeks postoperative visual analog scale score in the immediate injection group (3.2±2.46) was significantly higher than that in the 2 weeks postoperative injection group (5.1±2.68). The 3 months postoperative visual analog scale score/Lysholm score in the immediate injection group (2.72±2.70)/(80.58±15.63) were significantly higher than those in the 2 weeks postoperative injection group (4.72±3.07)/(64.96±21.68). The results indicate that sodium hyaluronate injection immediately after arthroscopic debridement of knee osteoarthritis is more favorable for recent rehabilitation.